Oneness Biotech Co (LUX:ONEA) Other Current Liabilities: $0.07 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LUX:ONEA Oneness Biotech Co Ltd LUX:ONEA
59 GF Score
Price $23.60
GF Value $40.21
! 4 Warning Signs
View Full Analysis

What is Oneness Biotech Co Other Current Liabilities?

Oneness Biotech Co LUX:ONEA 59 Other Current Liabilities is $0.07 Mil as of Dec. 2025. GuruFocus rates LUX:ONEA with a GF Score™ of 59/100 and a GF Value™ of $40.21. The stock has 4 warning signs investors should review.

Oneness Biotech Co's other current liabilities for the quarter that ended in Dec. 2025 was $0.07 Mil.

Oneness Biotech Co's quarterly other current liabilities declined from Jun. 2025 ($0.26 Mil) to Sep. 2025 ($0.09 Mil) and declined from Sep. 2025 ($0.09 Mil) to Dec. 2025 ($0.07 Mil).

Oneness Biotech Co's annual other current liabilities declined from Dec. 2023 ($1.12 Mil) to Dec. 2024 ($0.39 Mil) and declined from Dec. 2024 ($0.39 Mil) to Dec. 2025 ($0.07 Mil).

Oneness Biotech Co Other Current Liabilities Related Terms

Oneness Biotech Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Oneness Biotech Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oneness Biotech Co Other Current Liabilities Chart

Oneness Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.23 1.12 0.39 0.07

Oneness Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.33 0.26 0.09 0.07
LUX:ONEA
59GF Score
Oneness Biotech Co Ltd LUX:ONEA
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oneness Biotech Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.07 Mil mean?
Oneness Biotech Co (LUX:ONEA) has a Other Current Liabilities of $0.07 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Oneness Biotech Co.
Is Oneness Biotech Co's Other Current Liabilities too high?
Oneness Biotech Co's current Other Current Liabilities is $0.07 Mil. Overall, Oneness Biotech Co has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Oneness Biotech Co's Other Current Liabilities compare to VRTX and REGN?
Oneness Biotech Co's Other Current Liabilities of $0.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Oneness Biotech Co. Oneness Biotech Co's current Other Current Liabilities is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneness Biotech Co stock overvalued right now?
Oneness Biotech Co (LUX:ONEA) has a current Other Current Liabilities of $0.07 Mil. The stock's GF Value™ is $40.21, compared to a current price of $23.60 — trading 41.3% below its estimated fair value. The current Other Current Liabilities is $0.07 Mil. Oneness Biotech Co's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Oneness Biotech Co (LUX:ONEA), the current Other Current Liabilities is $0.07 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oneness Biotech Co (LUX:ONEA) Overvalued in 2026?

Based on GuruFocus' analysis, Oneness Biotech Co stock appears to be undervalued. The current stock price of $23.60 is trading 41.3% below its estimated GF Value™ of $40.21.

Key valuation signals for LUX:ONEA:

  • Other Current Liabilities: $0.07 Mil
  • GF Value™: $40.21 vs. price of $23.60 (41.3% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the LUX:ONEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oneness Biotech Co Business Description

Other Exchanges 4743:Taiwan
Address Zhongxiao West Road, No. 66, 35th Floor, Section 1, Zhongzheng District, Taipei, TWN, 100
Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The Group's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and Bonvadis, a wound care medical device. It also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, SNS851, and others. The Group operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation and organic food segment.
59GF Score

Get the complete analysis for LUX:ONEA

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.60
Price
$40.21
GF Value